Drug Topics

MARCH 13, 2025

US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.

562

562

PharmaVoice

MARCH 13, 2025

HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.

217

217

Drug Topics

MARCH 13, 2025

Approximately, 62% of respondents stated that the number of active drug shortages could potentially increase by more than 25% within the next 5 years.

516

516

Pharmacy Times

MARCH 13, 2025

Panelists discuss how health care professionals develop personalized menopause management strategies by comprehensively assessing individual medical history, symptom profiles, lifestyle factors, and potential risks. Through transparent, collaborative counseling, they guide patients in making informed decisions about pharmacologic therapies, prioritizing personalized care and holistic well-being.

65

65

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 13, 2025

Researchers compared changes in diet quality and waist-to-hip ratio during midlife with that of hippocampal connectivity and cognitive function in later life.

315

315

PharmaVoice

MARCH 13, 2025

The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.

147

147

Pharma Marketing Network

MARCH 13, 2025

Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.

59

59

Drug Topics

MARCH 13, 2025

With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.

247

247

DiversifyRx

MARCH 13, 2025

Pharmacy cash flow is still struggling even after the end of the DIR Fee Apocalypse DIR fees: the three letters that have kept pharmacy owners awake at night for years. Now that the so-called “DIR Fee Apocalypse” has come and gone, you might be thinking, “Finally, some relief!” But if youre anything like most independent pharmacy owners I talk to, youve realized that pharmacy cash flow problems dont magically disappear just because one storm has passed.

Independent Pharmacies 52

Independent Pharmacies Vaccines 52

Pharmacy Times

MARCH 13, 2025

By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.

117

117

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Marketing Network

MARCH 13, 2025

Table of Contents Understanding the Role of AI in Pharma Marketing Key Benefits of AI Integration in Pharma Marketing AI-Powered Strategies for Pharma Marketers Overcoming Challenges in AI Adoption Understanding the Role of AI in Pharma Marketing The pharmaceutical industry is undergoing a digital transformation, and AI in pharma marketing is at the forefront of this evolution.

HIPAA 52

HIPAA Customer Service FDA 52

Pharmacy Times

MARCH 13, 2025

Some of these approaches for chronic kidney disease (CKD) include cystatin C, SGLT2 inhibitors, point-of-care testing in remote areas, and acid-lowering medications.

116

116

Blog: Ask a Student Pharmacist

MARCH 13, 2025

Campus Preference and Assignment ceele001 Thu, 03/13/2025 - 15:22 The program is accredited for two performance sites, which include Rochester and the Twin Cities locations. Students can request the environment that best suits their needs. Our hybrid instruction model allows for faculty to teach the same courses and content at both performance sites.

Mayo Clinic 52

Mayo Clinic 52

Pharmacy Times

MARCH 13, 2025

Reported terminations and limitations on research projects studying vaccine hesitancy and strategies to increase vaccine uptake are poised to greatly impact studies of the phenomenon.

Vaccines 100

Vaccines 100

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

MARCH 13, 2025

Kelun-Biotech wins first global regulatory approval, in China, for a TROP2-directed antibody-drug conjugate (ADC) in lung cancer

75

75

Pharmacy Times

MARCH 13, 2025

Pharmacists are crucial in Elevidys administration, ensuring accurate dosing, coordinating treatment timing, and managing adverse effects to optimize patient outcomes.

81

81

Fierce Healthcare

MARCH 13, 2025

Executives from the country's largest for-profit health systems say Congress is receptive to their lobbying against changes to Medicare and Medicaid but acknowledge that some level of reform is likely in their future and will require operational pivots.

75

75

Pharmacy Times

MARCH 13, 2025

The Western diet was associated with increased risk of lung cancer.

73

73

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

MARCH 13, 2025

A new report by Clearwater Security found that healthcare companies owned by private equity firms lack documented cybersecurity policies and incident response plans.

Documentation 71

Documentation 71

Pharmacy Times

MARCH 13, 2025

Approximately 10% of patients with multiple myeloma have pathogenic germline variants, indicating a hereditary risk.

73

73

Fierce Healthcare

MARCH 13, 2025

A federal appeals court ruled that electronic health records company PointClickCare can't block health analytics firm Real Time Medical Systems from accessing patient data from its skilled nursing facility customers.

68

68

Pharmacy Times

MARCH 13, 2025

This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.

Hospitals 73

Hospitals 73

Pharmaceutical Technology

MARCH 13, 2025

Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latters biotech portfolio.

64

64

Pharmacy Times

MARCH 13, 2025

By saving time on mundane tasks, these tools allow pharmacists to focus on direct patient care.

Patient Care 65

Patient Care 65

Pharmaceutical Technology

MARCH 13, 2025

The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.

59

59

Pharmacy Times

MARCH 13, 2025

Panelists discuss how health care professionals recommend lifestyle modifications, dietary changes, and OTC products to manage menopause symptoms, focusing on exercise, nutrition, stress reduction, and targeted supplements to support overall well-being during this transitional period.

65

65

Pharmaceutical Technology

MARCH 13, 2025

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

59

59

Pharmacy Times

MARCH 13, 2025

Panelists discuss how patient characteristics significantly impact antibody-drug conjugate (ADC) therapy selection, with key factors including the presence and location of brain metastases (due to blood-brain barrier penetration), organ function and comorbidities affecting toxicity risks, and prior treatment history that may influence both efficacy and safety.

65

65

Pharmaceutical Commerce

MARCH 13, 2025

The CRDMOs acquisition of the Baltimore plant is expected to boost its biologics presence.

59

59

pharmaphorum

MARCH 13, 2025

Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy, Gedeon Richter's Ryeqo, via the NH

59

59

Pharmaceutical Technology

MARCH 13, 2025

Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug VT3989.

59

59

pharmaphorum

MARCH 13, 2025

Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery operations

59

59

Pharmaceutical Technology

MARCH 13, 2025

Whilst showing promise in cancer therapies, lead-212-based alpha emitters are hard to commercially supply.

59

59